Hanmi Science Co Ltd
KRX:008930
Intrinsic Value
Hanmi Science Co., Ltd. engages in the management of its subsidiaries. [ Read More ]
The intrinsic value of one
Hanmi Science Co Ltd
stock under the Base Case scenario is
28 143.59
KRW.
Compared to the current market price of 34 450 KRW,
Hanmi Science Co Ltd
is
Overvalued by 18%.
Hanmi Science Co Ltd's market capitalization is 2.3T KRW.
Hanmi Science Co Ltd stock price is 34 450 KRW.
Hanmi Science Co Ltd stock (28 143.59 KRW) is 18% less than its price (34450 KRW).
Hanmi Science Co Ltd stock (27 594.92 KRW) is 20% less than its price (34450 KRW). Open DCF Valuation
Hanmi Science Co Ltd stock (28 692.27 KRW) is 17% less than its price (34450 KRW). Open Relative Valuation
Hanmi Science Co Ltd has downside potential of 6% compared to the average analyst price target.
Open Wall St Estimates
Hanmi Science Co Ltd has positive Free Cash Flow for the last twelve months.
Hanmi Science Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 3% to 5%.
Hanmi Science Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 15%.
Hanmi Science Co Ltd has positive Gross Profit for the last twelve months.
Hanmi Science Co Ltd has positive three-year average ROE (Return on Equity): 8%. The company is efficient at transforming stockholders' equity into net income.
Hanmi Science Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 5%.
Hanmi Science Co Ltd's Revenue has grown by 19% over the past 12 months.
Hanmi Science Co Ltd has positive Net Income for the last twelve months.
Hanmi Science Co Ltd has positive Operating Income for the last twelve months.
Hanmi Science Co Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from 4% to 15%.
Hanmi Science Co Ltd's Revenue has been growing by 13% per year for the last 3 years.
Hanmi Science Co Ltd has a very low three-year average ROIC (Return on Invested Capital): 3%. The company is not efficient at using invested capital to generate operating income.
Hanmi Science Co Ltd's short-term liabilties (395B KRW) exceed its short-term assets (274B KRW).
Hanmi Science Co Ltd's long-term assets (1T KRW) exceed its long-term liabilties (439B KRW).
Hanmi Science Co Ltd has positive Net Debt. This means that the company has more debt (212B KRW) than cash and short-term investments (34B KRW).
Hanmi Science Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.27.
Hanmi Science Co Ltd generates enough operating income (57B KRW) to cover interest payments on its debt (10B KRW).
Hanmi Science Co Ltd's Altman Z-Score is very high and is equal to 5.46.
Valuation Backtest
Hanmi Science Co Ltd
Run backtest to discover the historical profit from buying and selling
Hanmi Science Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Hanmi Science Co Ltd
Balance Sheet Decomposition
Hanmi Science Co Ltd
| Current Assets | 273.9B |
| Cash & Short-Term Investments | 33.6B |
| Receivables | 108.8B |
| Other Current Assets | 131.6B |
| Non-Current Assets | 952.3B |
| Long-Term Investments | 775.4B |
| PP&E | 94.1B |
| Intangibles | 67.1B |
| Other Non-Current Assets | 15.7B |
| Current Liabilities | 395.2B |
| Accounts Payable | 59.8B |
| Accrued Liabilities | 13.2B |
| Short-Term Debt | 200.9B |
| Other Current Liabilities | 121.3B |
| Non-Current Liabilities | 43.5B |
| Long-Term Debt | 10.8B |
| Other Non-Current Liabilities | 32.7B |
Earnings Waterfall
Hanmi Science Co Ltd
|
Revenue
|
1.2T
KRW
|
|
Cost of Revenue
|
-1T
KRW
|
|
Gross Profit
|
235.6B
KRW
|
|
Operating Expenses
|
-178.6B
KRW
|
|
Operating Income
|
57B
KRW
|
|
Other Expenses
|
58.1B
KRW
|
|
Net Income
|
115.1B
KRW
|
Free Cash Flow Analysis
Hanmi Science Co Ltd
Profitability Score
Profitability Due Diligence
Hanmi Science Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Hanmi Science Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hanmi Science Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Hanmi Science Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hanmi Science Co Ltd
According to Wall Street analysts, the average 1-year price target for
Hanmi Science Co Ltd
is 32 381 KRW
.
Shareholder Return
Price
Hanmi Science Co Ltd
| Average Annual Return | -1.83% |
| Standard Deviation of Annual Returns | 70.92% |
| Max Drawdown | -72% |
| Market Capitalization | 2.3T KRW |
| Shares Outstanding | 66 198 323 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Hanmi Science Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Hanmi Science Co., Ltd. engages in the management of its subsidiaries. The company is headquartered in Hwaseong, Gyeonggi-Do. Through subsidiaries in Japan, Europe and Korea, the Company operates in three segments. The Pharmaceutical Products Wholesale segment mainly engages in the distribution of pharmaceutical products. The Holding Business segment mainly engages in the business of controlling subsidiaries. The Other segment mainly engage in the production and sales of pharmaceuticals, and the supply of quasi-drugs and health functional foods, beverages and functional cosmetics.
Contact
IPO
Employees
Officers
The intrinsic value of one
Hanmi Science Co Ltd
stock under the Base Case scenario is
28 143.59
KRW.
Compared to the current market price of 34 450 KRW,
Hanmi Science Co Ltd
is
Overvalued by 18%.
You don't have any saved screeners yet
